These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 3607761

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics.
    Stern H, Reilly R, Gallinger S, Kirsh J, DeAngelis C, Papa M, Hay K, Polihronis J, Schmoker B.
    Cancer Invest; 1993; 11(2):129-34. PubMed ID: 8462013
    [Abstract] [Full Text] [Related]

  • 23. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S, Divgi CR, Real FX, Yeh SD, Garin-Chesa P, Finstad CL, Sakamoto J, Cohen A, Sigurdson ER, Kemeny N.
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [Abstract] [Full Text] [Related]

  • 24. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW.
    Acta Cytol; 1987 Nov; 31(5):537-56. PubMed ID: 3314301
    [Abstract] [Full Text] [Related]

  • 25. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].
    Ohashi A.
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682
    [Abstract] [Full Text] [Related]

  • 26. Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
    Finstad CL, Lloyd KO, Federici MG, Divgi C, Venkatraman E, Barakat RR, Finn RD, Larson SM, Hoskins WJ, Humm JL.
    Clin Cancer Res; 1997 Aug; 3(8):1433-42. PubMed ID: 9815829
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.
    Meredith RF, Khazaeli MB, Grizzle WE, Orr RA, Plott G, Urist MM, Liu T, Russell CD, Wheeler RH, Schlom J.
    Hum Antibodies Hybridomas; 1993 Oct; 4(4):190-7. PubMed ID: 8257773
    [Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I, Schoonooghe S, Cornelissen B, Blanckaert P, Coene E, Cuvelier C, Mertens N, Slegers G.
    Clin Cancer Res; 2005 Oct 15; 11(20):7288-96. PubMed ID: 16243799
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
    Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P.
    Cancer Res; 1988 Aug 15; 48(16):4588-96. PubMed ID: 3396010
    [Abstract] [Full Text] [Related]

  • 32. Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.
    Hand PH, Calvo B, Milenic D, Yokota T, Finch M, Snoy P, Garmestani K, Gansow O, Schlom J, Kashmiri SV.
    Cancer Immunol Immunother; 1992 Aug 15; 35(3):165-74. PubMed ID: 1638552
    [Abstract] [Full Text] [Related]

  • 33. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
    Colcher D, Keenan AM, Larson SM, Schlom J.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5744-51. PubMed ID: 6498836
    [Abstract] [Full Text] [Related]

  • 34. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D, Milenic DE, Ferroni P, Carrasquillo JA, Reynolds JC, Roselli M, Larson SM, Schlom J.
    J Nucl Med; 1990 Jul 15; 31(7):1133-42. PubMed ID: 2362192
    [Abstract] [Full Text] [Related]

  • 35. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
    Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J.
    Cancer Res; 1988 Aug 15; 48(16):4597-603. PubMed ID: 3396011
    [Abstract] [Full Text] [Related]

  • 36. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
    Malamitsi J, Skarlos D, Fotiou S, Papakostas P, Aravantinos G, Vassilarou D, Taylor-Papadimitriou J, Koutoulidis K, Hooker G, Snook D.
    J Nucl Med; 1988 Dec 15; 29(12):1910-5. PubMed ID: 3193206
    [Abstract] [Full Text] [Related]

  • 37. Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.
    Zalutsky MR, Moseley RP, Benjamin JC, Colapinto EV, Fuller GN, Coakham HP, Bigner DD.
    Cancer Res; 1990 Jul 01; 50(13):4105-10. PubMed ID: 2162252
    [Abstract] [Full Text] [Related]

  • 38. A novel monoclonal antibody design for radioimmunotherapy.
    Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, Thornton J, Schlom J, LoBuglio AF.
    Cancer Biother Radiopharm; 2003 Oct 01; 18(5):751-9. PubMed ID: 14629823
    [Abstract] [Full Text] [Related]

  • 39. Human biodistribution of 111In-labeled B72.3 monoclonal antibody.
    Harwood SJ, Carroll RG, Webster WB, Zangara LM, Laven DL, Morrissey MA, Sinni BJ.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):932s-936s. PubMed ID: 2297744
    [Abstract] [Full Text] [Related]

  • 40. Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting.
    Schlom J, Hand PH, Greiner JW, Colcher D, Shrivastav S, Carrasquillo JA, Reynolds JC, Larson SM, Raubitschek A.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):820s-827s. PubMed ID: 1688734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.